Convincing evidence exists that a variety of
pollutants, some of which can disrupt endocrine development in wildlife and laboratory animals, is found in rain water, well water, lakes, and oceans, as well as freshwater, marine, and terrestrial food products. This paper identifies the need for a greater awareness about the long-term health consequences associated with exposure to endocrine-disrupting chemicals during early life. Endocrine-disrupting effects are not currently considered in assessing risks to humans, domestic animals, and wildlife. Taking into consideration what is currently known about chemicals that disrupt the endocrine system, the effects 1) may be manifested in an entirely different way, and with permanent consequences, in the early embryo, fetus, and neonate from effects as a result of exposure only in adulthood; 2) can change the course of development and potential of offspring, with the outcome depending on the specific developmental period(s) of exposure; and 3) are often delayed and thus may not be fully or obviously expressed until the offspring reaches maturity or even middle age, even though critical exposure occurred during early embryonic, fetal, or neonatal life.
In mammals as well as all other vertebrates, communication among cells is required for development to progress normally. Substances produced by one group of cells can direct the course of development and thus determine the future functioning of another group of cells (1) . For example, a group of compounds, the steroid hormones produced by the mother's ovaries and adrenal glands, the placenta, and the fetal gonads and adrenal glands, has been identified as playing a major role in regulating developmental processes in many tissues (2) . Organogenesis, a particularly vulnerable stage of development, begins in humans at the end of the second month of gestation. At this time the course of development of many tissues is regulated by endogenous steroid hormones along with other endocrine and paracrine factors (3) .
It is now recognized that numerous endocrine-disrupting chemicals have been released into the environment in large quantities since World War II (Table 1) . Some of these chemicals bind to intracellular receptor proteins for steroid hormones (4) and evoke hormonal effects in animals (5) , humans (6) , and cell culture (7, 8) . They thus interfere with the functioning of receptors whose normal role is to mediate the effects of the endogenous steroid hormones (9) . Laboratory experiments have demonstrated that exposure of fetuses to endocrine-disrupting chemicals can profoundly disturb organ differentiation (10, 11) (11) (12) (13) (14) (15) .
A major concern is the profound and permanent effects that exposure to endocrine disruptors during critical periods in development can have on the future wellbeing of wildlife and humans, although chronic exposure after maturity can also present a health risk. It is generally assumed that after maturity, exposure to endocrine disruptors does not permanently alter the functioning of hormone-responsive tissues. However, experimental studies in animals have shown permanent changes in brain (16) and vaginal epithelium (17) in females and prostate in males (18) (50, 51) . A major concern is that when women exposed in utero to estrogenic chemicals (DES and/or environmental pollutants that are estrogen agonists) reach the age at which the incidence of reproductive organ cancers normally increases, they will show a much higher incidence of cancer than unexposed individuals.
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There is a substantial literature documenting the detrimental effects of exposure to DES during the critical period of organ differentiation in experimental studies using rodents. Animal models corroborate clinical studies in humans. For example, dysplastic changes in the rodent prostate (53) are comparable to those seen in stillborn male offspring of women treated with DES (54). In female mice, DES exposure during early life leads to permanent cornification of the vaginal epithelium, which may be independent of effects on the brain-pituitary-ovarian axis (50,55,56). Significant impairment of immune function (particularly the T-cell system) has also been reported after exposure to DES during early life (57 as well as an increase in autoimmune diseases in women (58) . These outcomes were typically not noticeable at birth and often not detected before maturity. For example, treatment of male rats with DES during the first month after birth [accessory reproductive organs are still developing (2) ] did not result in observable malignancies at 6-9 months of age, but by 20 months (old age), squamous cell cancer was detected with involvement of the dorsolateral prostate (59) . In female mice treated during early life with DES, an increase in sensitivity of mammary glands to carcinogens has been reported (60) .
A variety of agricultural and industrial chemicals produced today (either within or outside the United States) are capable of binding to intracellular estrogen receptors either directly, such as o,p'-DDT (61) , or after in situ conversion to an active metabolite. For example, the pesticide methoxychlor (62) is demethylated in situ to a more estrogenic bisphenolic compound (63) . Pesticides such as o,p'-DDT, chlordecone (6), and components of plastics, such as nonylphenol (7), mimic the action of endogenous estrogens (and exogenous DES) both in laboratory animal models as well as in estrogen-sensitive cells in culture (8) . A number of conditions in wildlife (reviewed earlier) parallel those reported in laboratory animals and humans exposed to DES during development.
It is worth noting that the estrogenicity of chlordecone was first detected in people working at a pesticide-producing plant (64) , and although many effects of estrogenic chemicals may be primarily due to exposure during in utero development, chronic exposure throughout adulthood is also a concern. For example, in studies with male dogs, which show prostatic hyperplasia during aging, the disease only developed in castrated males treated with both androgen and estrogen, not androgen alone (18) . Exposure of adult men to estrogen has been implicated in the etiology of prostate hyperplasia (19, 65) (68, 69) , and 4) an approximate 50% decrease in sperm count worldwide over the last 50 years (70) .These trends may be a reflection of the increase from estrogenic pollutants in the environment. It has been suggested that the decrease in sperm count in men is the result of exposure during the fetal period of testicular differentiation to pollutants that have estrogenic activity (71) . For example, an association between reduced sperm motility and PCBs in men with fertility problems has been reported (72) ; some PCBs are directly estrogenic while others become estrogenic after in vivo conversion, although the binding affinity of estrogen receptors for estrogenic PCBs is lower than that for estradiol-1 7f (4) . Characterization of EndocrineDisrupting Chemicals
Literally thousands of synthetic compounds, a number of which are endocrine disruptors, have been released in the environment, generating concern about their additive and synergistic effects. Also, many of the endocrine disruptors are persistent, lipophilic, and have low vapor pressures, which facilitates their widespread dispersal.
It is common to find PCBs, dioxins, DDT, and a number of other organochlorine pesticides together in human breast milk and adipose tissue (73, 74) . Of concern for humans, domestic animals, and wildlife are the likely additive effects due to exposure to these and other endocrine-disrupting chemicals either together or at different times in life. For example, possible exposure to multiple estrogenic chemicals may be related to the fact that not all offspring of DES-exposed mothers show abnormalities. Although genetic factors may partially account for this outcome, it is also possible that the most affected individuals are those whose mothers were exposed to endocrine-disrupting environmental pollutants with estrogenic activity before or during treatment with DES. Many of the effects of endocrine disruptors that have been reported in wildlife are associated with the presence of a toxic contaminant in the mother due to exposure before egg production in birds and fish or pregnancy and lactation in mammals.
Evidence already exists that a number of organochlorine chemicals (such as dioxin, PCBs, and DDT) has reached concentrations in aquatic food sources that can lead to substantial functional deficits in animals that consume this food. Male rats fed Lake Ontario fish showed hyperreactivity to stress, and offspring of females fed Lake Ontario fish during pregnancy also expressed the same hyperreactive condition, although the offspring were never fed fish (75) . In addition, offspring of women who ate two to three Lake Michigan fish a month for at least 6 years preceding their pregnancies were slightly preterm, had lower birth weight, smaller skull circumference, and cognitive, motor (hypotonicity and hyporeflexivity), and behavioral deficits at birth compared with offspring whose mothers did not eat fish (76) . The effects were associated with the mothers' lifetime experience of eating fish, not just what they ate during pregnancy. These findings emphasize the importance of exposure of females to contaminants before pregnancy in terms of effects on their offspring.
Subsequent studies of the above cohort beginning at 6-7 months revealed delays in psychomotor development and poorer visual recognition compared with controls (77. When examined at 4 years of age, the children of women who had eaten fish in this study exhibited short-term memory problems, and 17 of the children became intractable and refused to cooperate during testing; they were the children of the mothers with the highest PCB concentrations (measured in their breast milk) in the study (78) . The childrens' intractable behavior appears to be analogous to the behavior of the rats fed Lake Ontario fish. In another study using the infants of mothers who ate Lake Michigan fish and infants of mothers exposed to a PCB "farm incident," both cohorts experienced growth retardation and neurological effects which were related in a dose-dependent manner to umbilical cord serum PCB concentrations (reflecting the levels in fetal blood) (79) . It remains to be determined whether the neurotoxic effects mentioned above are mediated through the endocrine system. It is recognized that endocrine-disrupting chemicals may act via multiple mechanisms, some of which may only operate during specific developmental periods (11, 80, 81) .
Based on current breast milk concentrations nationwide, it is estimated that at least 5% and possibly more of the babies born in the United States are exposed to quantities of PCBs sufficient to cause neurological effects (82) . These findings provide evidence that contemporary PCB exposure is above "any regulatory guideline" (82. 247). The possible immunological and endocrinological consequences remain to be determined in these cohorts. A major concern is that some of these consequences may not become apparent until young adulthood or even middle age.
Accumulation of pollutants increases the probability of repeated or constant exposure but, as the literature on dioxin shows, administration at only one time in development, rather than the more likely chronic exposure, can profoundly affect the embryo, fetus, or perinatal infant. Ample evidence exists from both in vivo and in vitro studies that dioxin can antagonize the action of estrogen in some estrogen target cells (83, 84) , although this effect does not appear to be due to dioxin binding to estrogen receptors (11) . The fact that dioxin is antiestrogenic is important because the conversion of androgen to estrogen in some target cells plays a critical role in masculinization (2) . For example, a series of studies describing the dose-related inhibition (dose range: 0.064-1.0 pg/kg! body weight to the dam) of masculinization and persistence of feminine traits in male rat offspring whose dams were fed one meal of dioxin during pregnancy at a critical period during sexual differentiation illustrates the vulnerability of the male rat fetus in utero to administration of only one low dose of dioxin to the dam. In these studies the effects were not fully manifested until the rats reached adulthood (85-84. These effects would be expected from either chronic, low-dose exposure to dioxin before pregnancy or to a single exposure during a critical time in pregnancy.
Dioxin accumulates in human tissue and is generally found in all tissues of people living in developed countries (88) . However, only the toxic congeners of the dioxin family complex bioaccumulate in human breast milk (88) . Similarly, these chemicals have also been found in follicular fluid obtained during in vitro fertilization procedures in women (89) . Although direct correlations
have not yet been reported between reproductive success and the presence of xenobiotics in the follicle, these substances could disrupt oocyte development (19, 90, 91) .
Many endocrine-disrupting chemicals have been reported in the reproductive tissues of men and women (74) . These lipidsoluble compounds appear to sequester in alt~fatty tissue in the body, so that organs and tissues with higher fat content hold more of the compounds on a wet weight basis (73) . Little is known about the concentrations in embryos and fetuses other than they appear to be similar to those in mothers (73, 92 . Of considerable concern is bioaccumulation of organochlorine chemicals in breast milk due to its high lipid content, which leads to a much higher concentration in breast milk than in maternal blood (73) . It is well documented that the infant is exposed to higher concentrations of many of these chemicals during breastfeeding than at any other time in its life (74) .
Consideration should also be given to the fact that man-made chemicals, such as DES, which bind to estrogen receptors in cells, do not bind to estrogen-binding plasma proteins (93) . One function of estrogen-binding plasma proteins, such as sexsteroid binding globulin in humans, is to restrict entry of endogenous estrogen into cells (94) . As a result of this affinity, only a small fraction of the total endogenous estrogen in blood is able to pass into cells. This is particularly important during pregnancy when the concentration of estrogenbinding plasma proteins increases dramatically (2, 95) . It is possible that estrogenlike chemicals may show low or no binding affinity to estrogen-binding plasma proteins. These chemicals may be able to freely enter cells (similar to DES), which would greatly increase their biological activity relative to similar blood concentrations of endogenous estrogen, most of which is inhibited from entering cells. This would contribute to the in vivo effectiveness of these pollutants, many of which show lower binding affinity to estrogen receptors than the most potent endogenous estrogen, estradiol-17fR (4) . Environmental pollutants with estrogenic activity are less potent agonists for the induction of proliferation of breast cancer cells in vitro (8) .
Summary
The deleterious effects of endocrine-disrupting chemicals in the environment on the reproductive success of wildlife populations have been documented; this is not an isolated problem, and today many wildlife populations are at risk. At present, no coherent policy has been articulated to remedy this problem. This is due in part to the lack of knowledge concerning which of the many chemicals present in the environment are responsible for endocrine-disrupting effects. Regulatory agencies should recognize that the current endpoints of most tests to assess the risk of pesticides and other pollutants (carcinogenicity, acute toxicity, and immediate mutagenicity) have led to the misconception that these chemicals do not pose a threat to the health of wildlife, domestic animals, or humans. Although the effects of mutagens can be seen immediately in terms of gross abnormalities, the consequences of fetal exposure to endocrine-disrupting chemicals would likely not be recognized until young adulthood, at which time abnormalities, particularly relating to the function of the reproductive system, become apparent.
Because endocrine-disrupting chemicals are in most cases neither mutagens nor acute toxicants at ambient concentrations, they may be released without proper caution into the environment. This may be partially remedied by screening for hormone agonistic and antagonistic activity using hormone-responsive cells in culture; this procedure identifies compounds that are endocrine disruptors because they are hormonally active (8) . Although this procedure cannot rule out chemicals devoid of hormonal activity that may disrupt development through other mechanisms, it can at least rule out compounds like DDT, chlordecone, alkylphenols, and some PCBs, which are estrogen agonists. It is also essential to continue to examine transgenerational effects in animal studies because some pollutants require metabolism in vivo to exert hormonal effects and because neurobehavioral and other developmental effects cannot be addressed with in vitro models (96, 97 
